Verified Treatment Center
Consortium Drug Abuse Rehabilitation Program
Philadelphia, PA · 19104
Key Takeaways for Consortium Drug Abuse Rehabilitation Program
- • SAMHSA-listed facility
- • Direct line available · Helpline free & confidential 24/7
About Consortium Drug Abuse Rehabilitation Program
Consortium Drug Abuse Rehabilitation Program is an addiction-treatment facility located in Philadelphia, PA. The specific care levels offered by Consortium Drug Abuse Rehabilitation Program should be confirmed directly with the admissions team. What follows is an orientation — not a review — to the practical questions worth asking before admission.
Care levels at Consortium Drug Abuse Rehabilitation Program
Care-level specifics for Consortium Drug Abuse Rehabilitation Program are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. The useful move is to have an ASAM-aligned assessment done before admission — ideally by someone outside the facility's admissions team — to confirm that the level of care offered here is what the clinical picture calls for.
Insurance and payment
Payment and insurance specifics for Consortium Drug Abuse Rehabilitation Program are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.
Before you call
Three questions to put to Consortium Drug Abuse Rehabilitation Program before admission: the specific ASAM level the facility is billing; the written Verification of Benefits for your specific plan product; the MAT policy (continuation of buprenorphine or methadone during residential, specifically). If the clinical situation involves opioid use disorder, confirm explicitly whether Consortium Drug Abuse Rehabilitation Program offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. Getting answers in writing protects against the downstream surprises.
Listing sourced from the SAMHSA Behavioral Health Treatment Services Locator. Data last synced April 2026. Verify current programs directly with the facility.
Consortium Drug Abuse Rehabilitation Program at a Glance
Insurance & Payment Accepted
Confirm in-network status before admission — verification is free.
Medicaid
Medicare
Private insurance
TRICARE / VA
Contact & Location
Address
451 University Ave., Philadelphia, PA 19104
Facility direct line
215-596-8000Website
www.consortium-inc.org